Newbury Pharmaceuticals AB historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2024-05-29 | 2.930 | 2.990 | 2.840 | 2.990 | 2.990 | 10,065 |
| 2024-05-28 | 3.000 | 3.000 | 2.700 | 2.890 | 2.890 | 49,655 |
| 2024-05-27 | 3.100 | 3.100 | 2.920 | 2.990 | 2.990 | 25,975 |
| 2024-05-24 | 3.140 | 3.200 | 3.010 | 3.120 | 3.120 | 32,765 |
| 2024-05-23 | 3.080 | 3.150 | 3.080 | 3.150 | 3.150 | 2,262 |
| 2024-05-22 | 2.970 | 3.180 | 2.970 | 3.160 | 3.160 | 40,051 |
| 2024-05-21 | 3.030 | 3.030 | 2.930 | 2.930 | 2.930 | 13,467 |
| 2024-05-20 | 3.040 | 3.100 | 2.950 | 3.020 | 3.020 | 23,260 |
| 2024-05-17 | 3.120 | 3.120 | 3.100 | 3.100 | 3.100 | 421 |
| 2024-05-16 | 3.120 | 3.120 | 3.120 | 3.120 | 3.120 | 0 |
| 2024-05-15 | 3.050 | 3.120 | 3.050 | 3.120 | 3.120 | 11,889 |
| 2024-05-14 | 3.140 | 3.140 | 3.050 | 3.060 | 3.060 | 4,956 |
| 2024-05-13 | 3.170 | 3.170 | 3.060 | 3.120 | 3.120 | 16,096 |
| 2024-05-10 | 3.100 | 3.270 | 3.090 | 3.270 | 3.270 | 11,623 |
| 2024-05-08 | 3.130 | 3.130 | 3.060 | 3.060 | 3.060 | 630 |
| 2024-05-07 | 3.030 | 3.050 | 3.030 | 3.050 | 3.050 | 2,719 |
| 2024-05-06 | 3.150 | 3.150 | 3.050 | 3.090 | 3.090 | 43,829 |
| 2024-05-03 | 3.200 | 3.980 | 2.750 | 3.230 | 3.230 | 264,509 |
| 2024-05-02 | 3.400 | 3.400 | 3.200 | 3.240 | 3.240 | 58,473 |
| 2024-04-30 | 3.410 | 3.410 | 3.410 | 3.410 | 3.410 | 0 |
| 2024-04-29 | 3.410 | 3.410 | 3.410 | 3.410 | 3.410 | 133 |
| 2024-04-26 | 3.320 | 3.550 | 3.310 | 3.410 | 3.410 | 29,767 |
| 2024-04-25 | 3.340 | 3.340 | 3.210 | 3.320 | 3.320 | 10,775 |
| 2024-04-24 | 3.390 | 3.390 | 3.270 | 3.350 | 3.350 | 20,330 |
| 2024-04-23 | 3.490 | 3.490 | 3.370 | 3.390 | 3.390 | 18,184 |
| 2024-04-22 | 3.490 | 3.490 | 3.490 | 3.490 | 3.490 | 31 |
| 2024-04-19 | 3.500 | 3.500 | 3.500 | 3.500 | 3.500 | 0 |
| 2024-04-18 | 3.500 | 3.500 | 3.500 | 3.500 | 3.500 | 0 |
| 2024-04-17 | 3.500 | 3.500 | 3.500 | 3.500 | 3.500 | 0 |
| 2024-04-16 | 3.430 | 3.600 | 3.380 | 3.500 | 3.500 | 97,138 |
| 2024-04-15 | 3.340 | 3.430 | 3.340 | 3.430 | 3.430 | 7,564 |
| 2024-04-12 | 3.420 | 3.420 | 3.420 | 3.420 | 3.420 | 2,005 |
| 2024-04-11 | 3.440 | 3.440 | 3.350 | 3.380 | 3.380 | 16,333 |
| 2024-04-10 | 3.470 | 3.470 | 3.340 | 3.410 | 3.410 | 36,505 |
| 2024-04-09 | 3.520 | 3.530 | 3.290 | 3.490 | 3.490 | 96,976 |
| 2024-04-08 | 3.510 | 3.510 | 3.510 | 3.510 | 3.510 | 11,028 |
| 2024-04-05 | 3.520 | 3.530 | 3.520 | 3.520 | 3.520 | 11,316 |
| 2024-04-04 | 3.490 | 3.580 | 3.460 | 3.580 | 3.580 | 580,955 |
| 2024-04-03 | 3.580 | 3.600 | 3.330 | 3.490 | 3.490 | 77,236 |
| 2024-04-02 | 3.600 | 3.600 | 3.510 | 3.540 | 3.540 | 65,048 |
| 2024-03-28 | 3.870 | 3.870 | 3.000 | 3.740 | 3.740 | 294,717 |
| 2024-03-27 | 3.840 | 3.840 | 3.840 | 3.840 | 3.840 | 450 |
| 2024-03-26 | 3.840 | 3.840 | 3.840 | 3.840 | 3.840 | 216 |
| 2024-03-25 | 3.830 | 3.830 | 3.830 | 3.830 | 3.830 | 535 |
| 2024-03-22 | 3.840 | 3.840 | 3.830 | 3.830 | 3.830 | 89 |
| 2024-03-21 | 3.710 | 3.800 | 3.710 | 3.800 | 3.800 | 987 |
| 2024-03-20 | 3.830 | 3.830 | 3.720 | 3.830 | 3.830 | 4,686 |
| 2024-03-19 | 3.830 | 3.830 | 3.710 | 3.710 | 3.710 | 467 |
| 2024-03-18 | 3.710 | 3.830 | 3.710 | 3.830 | 3.830 | 7,557 |
| 2024-03-15 | 3.550 | 3.710 | 3.550 | 3.710 | 3.710 | 20,350 |
| 2024-03-14 | 3.550 | 3.550 | 3.380 | 3.550 | 3.550 | 36,186 |
| 2024-03-13 | 3.680 | 3.780 | 3.600 | 3.600 | 3.600 | 23,209 |
| 2024-03-12 | 3.810 | 3.810 | 3.810 | 3.810 | 3.810 | 50 |
| 2024-03-11 | 3.790 | 3.810 | 3.790 | 3.810 | 3.810 | 1,200 |
| 2024-03-08 | 3.690 | 3.740 | 3.690 | 3.720 | 3.720 | 7,384 |
| 2024-03-07 | 3.680 | 3.680 | 3.680 | 3.680 | 3.680 | 500 |
| 2024-03-06 | 4.250 | 4.730 | 3.500 | 3.690 | 3.690 | 142,004 |
| 2024-03-05 | 4.260 | 4.260 | 4.250 | 4.260 | 4.260 | 6,395 |
| 2024-03-04 | 4.430 | 4.430 | 4.200 | 4.390 | 4.390 | 42,896 |
| 2024-03-01 | 4.360 | 4.490 | 4.360 | 4.430 | 4.430 | 24,871 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (SEK). Adjusted close accounts for splits and dividends. Educational only, not financial advice.